Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Medof

Showing results (41-50 of 126) with videos related to

Pageof 13
Sort By:
The Journal of Experimental Medicine|December 1, 1982
Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexesM E Medof, K Iida, C Mold, et al.
The American Journal of Pathology|January 1, 1996
Antigen-presenting cell engineering. The molecular toolboxM L Tykocinski, D R Kaplan, M E Medof
Methods in Enzymology|October 25, 2000
Glycerolphosphoinositide anchors for membrane-tethering proteinsJ D Fayen, M L Tykocinski, M E Medof
Archives of Biochemistry and Biophysics|August 23, 2001
Bulk production and functional analyses of mouse CD55's native and deglycosylated active domainsF Lin, R M Immormino, M Shoham, et al.
The Journal of Clinical Investigation|September 1, 1993
Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patientsR H Wang, G Phillips, M E Medof, et al.
Current Eye Research|January 14, 1998
Detection of complement regulatory proteins on soft contact lensesD S Bardenstein, S Sauer, L Szczotka, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1991
Assembly and deacetylation of N-acetylglucosaminyl-plasmanylinositol in normal and affected paroxysmal nocturnal hemoglobinuria cellsS Hirose, L Ravi, S V Hazra, et al.
Protein Engineering|December 1, 1996
Molecular modeling and mechanism of action of human decay-accelerating factorL Kuttner-Kondo, M E Medof, W Brodbeck, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1983
Requirement for human red blood cells in inactivation of C3b in immune complexes and enhancement of binding to spleen cellsM E Medof, T Lam, G M Prince, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1979
Study of circulating immune complexes in thyroid diseases: comparison of Raji cell radioimmunoassay and specific thyroglobulin-antithyroglobulin radioassayS Mariotti, L J DeGroot, D Scarborough, et al.
Pageof 13

Showing results (41-50 of 126) with videos related to

Sort By:
Pageof 13
The Journal of Experimental Medicine|December 1, 1982
Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexesM E Medof, K Iida, C Mold, et al.
The American Journal of Pathology|January 1, 1996
Antigen-presenting cell engineering. The molecular toolboxM L Tykocinski, D R Kaplan, M E Medof
Methods in Enzymology|October 25, 2000
Glycerolphosphoinositide anchors for membrane-tethering proteinsJ D Fayen, M L Tykocinski, M E Medof
Archives of Biochemistry and Biophysics|August 23, 2001
Bulk production and functional analyses of mouse CD55's native and deglycosylated active domainsF Lin, R M Immormino, M Shoham, et al.
The Journal of Clinical Investigation|September 1, 1993
Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patientsR H Wang, G Phillips, M E Medof, et al.
Current Eye Research|January 14, 1998
Detection of complement regulatory proteins on soft contact lensesD S Bardenstein, S Sauer, L Szczotka, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 1, 1991
Assembly and deacetylation of N-acetylglucosaminyl-plasmanylinositol in normal and affected paroxysmal nocturnal hemoglobinuria cellsS Hirose, L Ravi, S V Hazra, et al.
Protein Engineering|December 1, 1996
Molecular modeling and mechanism of action of human decay-accelerating factorL Kuttner-Kondo, M E Medof, W Brodbeck, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 1, 1983
Requirement for human red blood cells in inactivation of C3b in immune complexes and enhancement of binding to spleen cellsM E Medof, T Lam, G M Prince, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1979
Study of circulating immune complexes in thyroid diseases: comparison of Raji cell radioimmunoassay and specific thyroglobulin-antithyroglobulin radioassayS Mariotti, L J DeGroot, D Scarborough, et al.
Pageof 13